Immunological Strategies in Gastric Cancer: How Toll-like Receptors 2, -3, -4, and -9 on Monocytes and Dendritic Cells Depend on Patient Factors?
Cells · 2024
DOI: 10.3390/cells13201708 ↗Kurz gefasst
Fachartikel in der Zeitschrift Cells, 2024. Verfasst von Marek Kos und 6 weiteren Autor:innen. Beteiligte Einrichtung: Department of Public Health, Medical University of Lublin, 1 Chodźki Street, 20-093 Lublin, Poland. Hauptthemen laut MEDLINE: Stomach Neoplasms, Monocytes, Dendritic Cells, Toll-Like Receptor 2. Die Arbeit wurde bisher 4-mal zitiert (Crossref) und nennt 85 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: Medical University of Lublin.
Abstract (Originalsprache)
(1)
Introduction
Toll-like receptors (TLRs) are key in immune response by recognizing pathogen-associated molecular patterns (PAMPs) and damage-associated molecular patterns (DAMPs). In gastric cancer (GC), TLR2, TLR3, TLR4, and TLR9 are crucial for modulating immune response and tumor progression. (2)
Objective
This study aimed to assess the percentage of dendritic cells and monocytes expressing TLR2, TLR3, TLR4, and TLR9, along with the concentration of their soluble forms in the serum of GC patients compared to healthy volunteers. Factors such as disease stage, tumor type, age, and gender were also analyzed. (3) Materials and Methods: Blood samples from newly diagnosed GC patients and healthy controls were immunophenotyped using flow cytometry to assess TLR expression on dendritic cell subpopulations and monocytes. Serum-soluble TLRs were measured by ELISA. Statistical analysis considered clinical variables such as tumor type, stage, age, and gender. (4)
Results
TLR expression was significantly higher in GC patients, except for TLR3 on classical monocytes. Soluble forms of all TLRs were elevated in GC patients, with significant differences based on disease stage but not tumor type, except for serum TLR2, TLR4, and TLR9. (5)
Conclusions
Elevated TLR expression and soluble TLR levels in GC patients suggest a role in tumor pathogenesis and progression, offering potential biomarkers and therapeutic targets.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Department of Public Health, Medical University of Lublin, 1 Chodźki Street, 20-093 Lublin, Poland.
- General Surgery Department, SP ZOZ in Leczna, 52 Krasnystawska Street, 21-010 Leczna, Poland.
- Department of Experimental Immunology, Medical University of Lublin, 4a Chodźki Street, 20-093 Lublin, Poland.
- Department of Anesthesiology and Intensive Care, SP ZOZ in Leczna, 52 Krasnystawska Street, 21-010 Leczna, Poland.
- Department of General and Oncological Surgery, Faculty of Medicine, Medical University of Lodz, 251 Street, 92-213 Lodz, Poland.
ORCID-Profile: Paulina Mertowska, Sebastian Mertowski, Piotr Tomaka, Ewelina Grywalska
Förderung
- Medical University of Lublin
Zitieren
APA
Kos, M., Bojarski, K., Mertowska, P., Mertowski, S., Tomaka, P., Dziki, Ł., & Grywalska, E. (2024). Immunological Strategies in Gastric Cancer: How Toll-like Receptors 2, -3, -4, and -9 on Monocytes and Dendritic Cells Depend on Patient Factors?. Cells. https://doi.org/10.3390/cells13201708
Vancouver
Kos M, Bojarski K, Mertowska P, Mertowski S, Tomaka P, Dziki Ł, et al. Immunological Strategies in Gastric Cancer: How Toll-like Receptors 2, -3, -4, and -9 on Monocytes and Dendritic Cells Depend on Patient Factors?. Cells. 2024. doi:10.3390/cells13201708
BibTeX
@article{Kos2024,
author = {Kos, Marek and Bojarski, Krzysztof and Mertowska, Paulina and Mertowski, Sebastian and Tomaka, Piotr and Dziki, Łukasz and Grywalska, Ewelina},
title = {Immunological Strategies in Gastric Cancer: How Toll-like Receptors 2, -3, -4, and -9 on Monocytes and Dendritic Cells Depend on Patient Factors?},
journal = {Cells},
year = {2024},
doi = {10.3390/cells13201708}
}
EUVIMED